Problem 161 - Objective Biology for NEET

Question

Assertion: The reduction in number of platelets can lead to clotting disorders. Reason: Platelets release a variety of sustances most of which are involved in the clotting of blood.

Step-by-Step Solution

Answer

The reason provided is a valid explanation for the assertion as both are scientifically accurate and directly related: decreased platelet count would lead to less release of blood clotting substances disrupting the process and leading to clotting disorders.

Step 1: Understanding the Assertion

The assertion states: The reduction in number of platelets can lead to clotting disorders. Platelets are a crucial component of the blood, responsible for clotting to prevent excessive bleeding. A reduction in their number can therefore disrupt this clotting function leading to disorders.

Step 2: Understanding the Reason

The reason given is: Platelets release a variety of substances most of which are involved in the clotting of blood. This is biologically accurate since platelets do release substances like thromboxane A2 and serotonin which aid the clotting process. A reduction would mean fewer such substances, impacting clotting.

Step 3: Linking Assertion and Reason

Now, it's clear that the platelets play a critical role in blood clotting by releasing various clot-enhancing substances. A decrease in their number would logically mean less of these substances, and therefore, less effective clotting. Thus, clotting disorders could indeed be a result of reduced platelet number.

Key Concepts

Blood Clotting

Blood clotting, also known as coagulation, is the body's natural mechanism to prevent excessive bleeding when blood vessels are injured.
When a blood vessel tears, the body triggers a series of reactions to stop bleeding by forming a clot.
The clot acts as a temporary seal that protects the body until the tissue can be repaired. The clotting process involves several steps:

• First, the blood vessels constrict to reduce blood flow.
• Then, platelets are activated and form a temporary, loose platelet plug.
• Finally, various proteins in the blood, known as clotting factors, reinforce the platelet plug with a fibrin mesh that hardens to complete the clot formation.

Platelets play a critical role in the initial and final stages of clotting by providing the necessary substances and structural framework to solidify the clot.

Clotting Disorders

Clotting disorders are conditions that affect the body’s ability to prevent excessive bleeding or clot formation.
These disorders can occur due to a lack of specific proteins or enzymes required for effective blood coagulation or due to malfunctions in platelet production.
Common clotting disorders include:

• Hemophilia, a genetic disorder where blood doesn’t clot properly due to missing or deficient clotting proteins.
• Thrombocytopenia, a condition characterized by low platelet counts leading to increased bleeding risks.

Clotting disorders can lead to symptoms ranging from easy bruising and prolonged bleeding from cuts, to more severe internal bleeding.
Treatment often involves medication to increase platelet counts or replace missing clotting factors.

Thromboxane A2

Thromboxane A2 is a potent compound released by activated platelets during the blood clotting process.
It plays a pivotal role by:

• Facilitating platelet aggregation, which is the clumping together of platelets to form a stable plug.
• Promoting vasoconstriction, which reduces blood flow to the site of injury and aids in the clotting process.

Due to its crucial functions in clot formation, thromboxane A2 has been a target in the treatment and prevention of clotting-related disorders such as coronary artery diseases.
Medications like aspirin work by inhibiting the action of thromboxane A2, hence reducing the risk of abnormal clot formation.

Serotonin

Serotonin is often recognized as a neurotransmitter that contributes to feelings of well-being and happiness, but it also serves an important role in blood clotting.
Released by platelets, serotonin aids in the clotting process by:

• Promoting vasoconstriction, which helps to narrow blood vessels and reduce blood loss at the site of injury.
• Enhancing the stability and strength of the forming clot.

Although its primary action is in the nervous system, in the context of platelets, serotonin plays an integral role in ensuring efficient clot formation.
An imbalance in serotonin levels, for instance due to certain disorders or medications, can impact clotting efficiency.

Blood Components

Blood consists of various components, each with specialized functions essential for maintaining health and homeostasis.
The primary components of blood include:

• Red Blood Cells (RBCs), which transport oxygen to tissues.
• White Blood Cells (WBCs), which are part of the immune system and defend against infections.
• Platelets, small cell fragments vital for blood clotting.
• Plasma, the liquid component that carries nutrients, hormones, and proteins throughout the body.

Each component works in concert to support life by ensuring efficient transport of gases, nutrients, and waste, while also providing defense mechanisms and tissue repair.
Understanding the role of each component is crucial, especially in the context of clotting where platelets play a central role by releasing clot-promoting substances.